'No benefit' from hydroxychloroquine for Covid-19: major UK trial
Add BT as a preferred source
[PARIS] A major British trial of hydroxychloroquine has found it has "no benefit" for patients hospitalised with Covid-19, researchers said Friday, announcing they had halted tests of the drug.
"We have concluded that there is no beneficial effect of hydroxychloroquine in patients hospitalised with Covid-19," said a statement from the chief investigators in the randomised clinical trial, which is run by the University of Oxford and is testing a number of potential treatments for the new coronavirus.
They added they would stop recruiting patients to the hydroxychloroquine part of the trial "with immediate effect".
AFP
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Share with us your feedback on BT's products and services
